Exocure Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series 2

  • Latest Deal Amount
  • $170K

  • Investors
  • 1

Exocure General Information

Description

Developer of exosome delivery-based platforms for targeted drug delivery and synergistic immune modulation. The company's platform develops highly efficient proprietary exosome isolation methods for gene therapy and cancer treatment, enabling clinicians to develop advanced medicines to achieve progress of incurable diseases.

Contact Information

Website
www.exocure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Erik Dahlbergsgatan 11
  • 411 26 Gothenburg
  • Sweden
+46 070-820
Primary Industry
Biotechnology
Corporate Office
  • Erik Dahlbergsgatan 11
  • 411 26 Gothenburg
  • Sweden
+46 070-820

Exocure Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exocure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 12-Aug-2025 $170K Completed Pre-Clinical Trials
2. Angel (individual) 01-Jan-2023 Completed
1. Accelerator/Incubator 02-Feb-2024 $2M $2M Completed Pre-Clinical Trials
To view Exocure’s complete valuation and funding history, request access »

Exocure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view Exocure’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Exocure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exocure Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
GU Ventures Accelerator/Incubator Minority
To view Exocure’s complete investors history, request access »

Exocure Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Panexo Biosciences Goteborg, Sweden 2023

Exocure FAQs

  • When was Exocure founded?

    Exocure was founded in 2023.

  • Where is Exocure headquartered?

    Exocure is headquartered in Gothenburg, Sweden.

  • What is the size of Exocure?

    Exocure has 4 total employees.

  • What industry is Exocure in?

    Exocure’s primary industry is Biotechnology.

  • Is Exocure a private or public company?

    Exocure is a Private company.

  • What is the current valuation of Exocure?

    The current valuation of Exocure is .

  • What is Exocure’s current revenue?

    The current revenue for Exocure is .

  • How much funding has Exocure raised over time?

    Exocure has raised $2.65M.

  • Who are Exocure’s investors?

    GU Ventures has invested in Exocure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process